ask="1.90"
ask_size="1600"
average_daily_volume="718292"
bid="1.59"
bid_size="600"
book_value="1.07"
change="+0.02"
change_from_200_day_moving_average="-0.40"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-4.09"
change_From_52_week_low="0.72"
change_in_percent="+1.20%"
close="1.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.01"
ebitda="-16.58M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.06"
eps_estimate_next_year="-0.28"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.69"
high_52_weeks="5.77"
last_trade_date="2/8/2017"
last_trade_price="1.68"
last_trade_size="361"
last_trade_time="3:59pm"
low="1.61"
low_52_weeks="0.96"
market_capitalization="19.64M"
moving_average_200_day="2.08"
moving_average_50_day="1.49"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-19.38%"
percent_change_from_50_day_moving_average="+12.50%"
percent_change_from_52_week_high="-70.87%"
percent_change_from_52_week_low="+75.00%"
previous_close="1.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.18"
stock_exchange="NCM"
symbol="PZRX"
volume="20946"
weeks_range_52="0.96 - 5.77"
